Abstract
Objective:
Aortic diseases involving branches of the visceral arteries mainly include thoracoabdominal aortic aneurysm (TAAA), aortic dissection (AD) and abdominal aortic aneurysm (AAA). The focus of treatment is to reconstruct the splanchnic arteries and restore blood supply to the organs. Commonly used methods include thoracoabdominal aortic replacement, thoracic endovascular aortic repair and hybrid approaches. Hybrid surgery for aortic disease involving the visceral arteries, consisting of visceral aortic debranching with retrograde revascularization of the celiac trunk and renal arteries and using stent grafts, has been previously described and may be considered particularly appealing in high-risk patients. This study retrospectively analyzed recorded data of patients and contrasted the outcomes with those of a similar group of patients who underwent conventional open repair surgery.
Methods:
Between 2019 and 2022, 72 patients (52 men) with an average age of 61.57 ± 8.66 years (range, 36–79 years) underwent one-stage debranching abdominal aortic hybrid surgery. These patients, the hybrid group, underwent preoperative Computed Tomographic Angiography (CTA) and had been diagnosed with aortic disease (aneurysm or dissection) involving the visceral arteries and were at high risk for open repair. The criteria used to define these patients as high-risk group who are in the need of hybrid treatment were American Society of Anesthesiologists (ASA) class 3 or 4. In all cases, we accomplished total visceral aortic debranching through a previous visceral artery retrograde revascularization with synthetic grafts (customized Y or four-bifurcated grafts), and aortic endovascular repair with one of two different commercially produced stent grafts (Medtronic® and Lifetech®). In some cases, we chose to connect the renal artery to the artificial vessel with a stent graft (Viabahn) and partly or totally anastomosed. We analyzed the results and compared the outcomes of the hybrid group with those of a similar group of 46 patients (36 men) with an average age 54.15 ± 12.12 years (range, 32–76). These 46 patients, the conventional open group, were selected for having had thoracoabdominal aortic replacement between 2019 and 2022.
Results:
In the hybrid group, 72 visceral bypasses were completed, and endovascular repair was successful in all cases. No intraoperative deaths occurred. Perioperative mortality was 2.78%, and perioperative morbidity was 9.72% (renal insufficiency in 1, unilateral renal infarction in 5, Intestinal ischemia in 1). At 1-month postoperative CTA showed 2 endoleaks, one of which was intervened. At follow-up, there were unplanned reoperation rate of 4.29% and 5 (7.14%) deaths. The remaining patients’ grafts were patent at postoperative CTA and no endoleak or stent graft migration had occurred. In the conventional open group, 1 died intraoperatively, 4 died perioperatively, perioperative mortality was 10.87% and complications were respiratory failure in 5, intestinal paralysis/necrosis in 4, renal insufficiency in 17, and paraplegia in 2. At follow-up, 5 (12.20%) patients presented with synthetic grafts hematoma 4 (9.76%) patient died, and 6 (14.63%) patients required unplanned reoperation intervention.
Conclusion:
Hybrid surgery is technically feasible in selected cases. For aortic diseases involving the visceral arteries, the application of hybrid abdominal aorta debranching can simplify the operation process, decrease the risks of mortality and morbidity in high-risk and high-age populations and decrease the incidence of various complications while achieving ideal early clinical efficacy. However, a larger series is required for valid statistical comparisons, and longer follow-ups are necessary to evaluate the long-term efficacy of hybrid surgery.
Introduction
The visceral arterial branches mainly involve the renal arteries, the celiac trunk artery and the superior mesenteric artery (). Aortic diseases involving branches of the visceral arteries mainly include thoracoabdominal aortic aneurysm (TAAA), aortic dissection (AD) and abdominal aortic aneurysm (AAA) (–). A common feature of a classic TAAA, as well as some diseases such as AD and AAA, is that the diseases may involve the visceral arteries and, in the surgical procedure, reconstruction of these visceral arterial branches is possible. Currently, the main modalities for the treatment of abdominal aortic disease are thoracoabdominal aortic replacement, endovascular aortic repair (EVAR) and hybrid approaches ().
Since its first description in 1955, open repair has been considered the gold standard of treatment for aortic diseases and remains among the most difficult surgical approach due to the associated vital structures, such as the mesenteric/renal branches and the segmental arteries involved in the lesion (). For aortic diseases involving the visceral artery branches, it is necessary to reconstruct the visceral artery branches while treating the aortic disease (). Due to the long operation time and extensive trauma, various serious perioperative complications, such as internal organ ischemia, massive intraoperative hemorrhage, paraplegia, renal failure, and infection, are possible and the risk of mortality is high (, ).
Another alternative approach to traditional open repair is EVAR with endograft techniques (). There is no doubt that a total endovascular approach would benefit patients with aortic diseases, but individualized stents may take years to become widely available (). Treatment modalities consisting of visceral parallel graft (chimney/snorkel) techniques with off-the-shelf devices have a greater probability of causing complications such as endoleaks and displacements, so EVAR is now more beneficial for treating subrenal aortic diseases (, ). Three-dimensional, laser and customized branch/bifurcation stent grafts are now available for the treatment of TAA (–).
Hybrid approaches consisting of visceral aortic debranching with retrograde revascularization of the mesenteric, coeliac trunk and renal arteries and aortic lesion exclusion using commercially available stent grafts have been described in several reports (, ). This study analyzed recorded data of a series of high-risk patients with a history of aortic surgery who underwent hybrid repair for aortic diseases at some institutes in the last 4 years and compared the outcomes in this group with those in a similar group of patients who underwent conventional open repair for aortic diseases. The aim of this paper is to introduce a relatively less invasive surgical approach for patients who may have had total thoracoabdominal aortic replacement in the past.
Patients and methods
Between 2019 and 2022, 72 patients (52 men) with a mean age of (61.57 ± 8.66) years (range, 36–79 years) underwent a one-stage debranching abdominal aortic hybrid procedure at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Changhai Hospital, Naval Medical University, and other centres. These patients, the hybrid group, underwent preoperative Computed Tomographic Angiography (CTA) (Figure 1) and had been diagnosed with aortic disease (aneurysm or dissection) involving the visceral arteries. The group was assessed preoperatively as being at high risk and the criteria used to define these at-risk groups in need of hybrid surgery were American Society of Anesthesiologists (ASA) Level 3 or 4. At the same time, we selected a similar group of 46 patients (36 men) who had undergone thoracoabdominal aortic replacement between 2019 and 2022 as the conventional open group, whose mean age was (54.15 ± 12.12) years (range, 32–76 years). We analyzed the results and compared these results with the hybrid group. The aim of this study was to describe how to use the hybrid procedure in high-risk and high-age populations.
Figure 1
Hybrid group
Beginning in 2019, 72 high-risk patients underwent one-stage stent graft repair with visceral aortic debranching and prior retrograde revascularization of visceral arteries. The criteria we used to define these patients as being at high risk for conventional repair were American Society of Anesthesiologists (ASA) class 3 or 4.
All patients underwent a one-stage procedure performed in the operating room. All patients were operated on under general anesthesia with tracheal intubation. The abdominal aorta, common iliac arteries, and the first 2 cm from the origin of the common hepatic artery, superior mesenteric artery, and renal arteries were exposed, when needed, through a transperitoneal midline approach with the patient in a supine position. Synthetic grafts with diameters of 6 or 8 mm and 10 were used in all patients. We preferably used customized Y grafts or separated bypass grafts, or both, and four-bifurcated grafts for each recipient vessel. In some cases, we accomplished total visceral aortic debranching through a previous visceral artery retrograde revascularization with four-bifurcated grafts.
There are two inflow site options: the prograde route (diversion from the ascending aorta) and the retrograde route (diversion from the iliac artery and distal abdominal aorta). We generally choose the retrograde route. The choice of inflow site for retrograde visceral artery bypass grafting was based on the extent of the lesion, the presence of prior abdominal aortic repair, and the quality of the walls of the native aorta and iliac arteries. The proximal segment of this iliac artery was blocked, an incision of approximately 10 mm was made in the wall of the iliac artery, and this incision was continuously anastomosed end-to-side with the opening of the two-branch artificial vessel. Each stitch needs to be tightened to avoid twisting, stenosis and anastomotic leakage due to improper placement of the artificial vessel.
Reconstruction of the outflow pathways allowed reconstruction of the visceral arterial branches. All the donor vessels were anastomosed end-to-side (Figure 2).
Figure 2
For celiac trunk revascularization, the graft was routed through the middle of the omental sac, either behind or in front of the pancreas, an arteriotomy was made in the common hepatic artery or the splenic artery, and an end-to-side anastomosis was made. If the proximal abdominal trunk is not tied, a type 2 endoleak can develop, so it is essential to prevent spinal cord ischemia and eliminate the need for cerebrospinal drainage to the same extent as in the open branch technique.
An end-to-side anastomosis of the superior mesenteric artery was made next to the flexor ligament. During the operation, part of the flexor ligament should be preserved, the duodenum should not be excessively dissected, and the formation of an acute angle between the bridge vessels and the superior mesenteric artery should be avoided after mesenteric repositioning.
When anastomosis of the renal artery was required for reconstruction, the kidney was wrapped in ice slush before and during renal artery cross-clamping and the temperature was lowered from 15°C to 18°C. An end-to-end anastomosis was performed when the renal artery was deep, and an end-to-side anastomosis was performed when the renal artery was shallow. To save time in reconstructing the renal artery, we usually used a Viabahn (GORE®) with a diameter of 6 or 7 mm and a length of 10 cm (depending on the diameter of the involved renal artery as measured by the preoperative CTA) that connected the artificial vessel to the renal artery. Renal warm ischemia time was limited to 2 min with Viabahn, so ice slush was not used for renal hypothermia (). A bypass graft (6 mm in diameter) was sutured to the Y graft, which underwent end-to-side anastomosis with the iliac artery. A guidewire was introduced into the presutured graft over which the Viabahn was advanced. An opening was made in the anterior wall of the renal artery, and the guidewire was introduced distal to the renal artery. The Viabahn was then advanced through the guidewire into the renal artery to a certain distance as measured by preoperative CTA. A silk knot or suture was used to secure the stent to the outside of the artificial vessel.
In all the reconstructions, the grafted vessels were ligated proximally to prevent retrograde perfusion of the sac after endovascular exclusion of the aneurysm. The grafts were then covered with retroperitoneum or an omental flap whenever possible.
The access vessel for endograft insertion was the common femoral artery (exposed through an inguinal incision). Two stent grafts (Medtronic® and Lifetech®) were used, and 1–3 stent grafts were deployed in each patient. Complete aortography was performed after deployment of the endografts (Figure 3).
Figure 3
All patients were transferred to the intensive care unit (ICU) after the operation. Antiplatelet therapy (aspirin) was begun on the first postoperative day and was maintained for at least 3 months. Sensation and movement of the lower extremities, postoperative morbidity and short-term mortality were recorded. CTAs were performed at 3, 6, or 12 months after the operation in all the survivors and were carefully compared with the preoperative total CTAs to evaluate renal artery patency, to assess the stent and bypass grafts, and to identify renal infarction, bleeding at the anastomosis, and stent-grafter elated complications, such as migration, kinking, or fracture.
Conventionally treated group
From the entire series of patients who had undergone thoracoabdominal aortic replacement after 2019, we selected 46 patients (36 men) who had undergone prior aortic surgery (19.57% ascending, 15.22% descending, and 2.17% abdominal aortic repair) and had an ASA classification of 3 or 4.
All procedures were performed electively. Cell salvage, rapid infusers, and transfusion were used. All patients were operated on under general anesthesia, tracheal intubation and respiratory ventilation.
The surgery was performed from the left posterolateral 6th or 7th intercostal space to the inferior border of the costal arch and continued to the left rectus abdominis muscle. Depending on the extent of the lesion, the surgery can extend to the iliac fossa, allowing the opening of the diaphragm to expose and explore the thoracoabdominal aorta. Distal aortic perfusion with left atrial femoral artery bypass or hypothermic visceral perfusion with or without cerebrospinal fluid drainage was routinely used (). Four branches of aortic grafts with diameters of 26 and 28 mm (branch diameter of 8 or 10 mm) were used in all patients. Reconstruction of the proximal aorta, visceral artery branches, and distal aorta was accomplished after sequential segmental block. End-to-end anastomosis was performed between these arteries and the graft. In some patients, the arterial wall containing the opening of the celiac trunk, superior mesenteric artery, and right renal artery could be directly anastomosed to the sidewall of the graft, and an end-to-side anastomosis of the left renal artery was performed separately. The patent intercostal arteries below the 8th thoracic vertebra were reconstructed, and the remaining occluded intercostal arteries were sutured. In cases of dissection/aneurysm involving the abdominal aortic bifurcation and below, the graft branches were anastomosed downward to the iliac artery.
Patients were evaluated with postprocedural CTA at 3, 6 and 12 months and yearly thereafter. Clinical follow-up was also conducted every 6 months. We analyzed the outcomes in our patients, reporting the results and methods.
Results
Hybrid group
Debranching abdominal aortic hybrid surgery of aortic diseases involving visceral arteries in all 72 patients. No intraoperative deaths occurred. Because we performed this procedure on some of our patients at other heart centers, we lost some of the patient data from the procedure. By analyzing the perioperative data of 72 patients, we mainly analyzed the incidence of postoperative complications and mortality.
The hybrid repair was clinically successful in 70 (97.22%) of 72 patients (Figure 4). Two patients died postoperatively for a mortality rate of 2.78%: one related to disseminated or diffuse intravascular coagulation (DIC) and one from ruptured aneurysm. Other postoperative complications included acute renal failure in one patient (1.39%) that resolved without dialysis that was considered as occlusion of the bridge vessel on one side and failure of revascularization on the other side, 5 patients (6.94%) presented with unilateral renal infarction considered to be bridge vessel occlusion, and one (1.39%) presented with left hemicolectomy necrosis considered the inferior mesenteric artery was not revascularized because of high regurgitant pressure.
Figure 4
During the follow-up period patients had one bridge vessel occlusion requiring unplanned reoperation (A patient was found to have renal artery occlusion due to VB displacement during the 5-years post-operative review. After dilatation with a balloon, the renal artery was recanalized.), two endoleaks requiring unplanned reoperation management (unplanned reoperation rate of 4.29%), one pulmonary infection due to aneurysm compression, and 5 (7.14%) deaths. In total, there were even 7 (9.72%) surgical and aneurysm-related deaths.
Conventionally treated group
One intraoperative death occurred. The mean procedure time was 398 ± 143 min. A mean of 5.4 ± 6.4 U of packed red blood cells was transfused for a median blood loss of 1852 ± 2124 ml. There were 4 postoperative deaths. Perioperative mortality was 10.87%. Perioperative complications included 2 patients with permanent paraplegia, 4 with intestinal paralysis/necrosis, 4 patients with unilateral renal infarction, 4 with venous thrombosis (one of which was a pulmonary embolism), 17 with renal failure, 7 with surgical site infection, 2 with graft infection, and 19 with pulmonary infection and 5 with respiratory failure. All patients were admitted to the intensive care unit, where the stayed for a mean of 4.30 ± 3.35 days.
At post-discharge follow-up, there were 4 (9.76%) deaths here, 6 (14.63%) patients required unplanned reoperation intervention (2 of EVAR, 2 of chest wall debridement and suturing, 1 of thoracotomy hemostasis and 1 of abdominal hemostasis), and 5 (12.20%) patients presented with synthetic grafts hematoma. The overall surgical and aneurysm-related death rate was 19.57%.
The age of the hybrid group was significantly higher than that of the conventional group, as the hybrid surgery was used preferentially on people who were at high-risk or of high-age (61.57 ± 8.66, 54.15 ± 12.12; respectively; p < 0.05). The rates of complication such as renal failure, respiratory failure, and lower extremity thrombosis within 30 days of hybrid surgery were also significantly lower in the hybrid surgery group than in the conventional surgery group (p < 0.05) (Table 1). Although there was no significant difference in mortality and unplanned reoperation rates between the hybrid and conventional treatment groups, the desired results were achieved in an older age group.
Table 1
| Hybrid group | Conventionally treated group | p | |
|---|---|---|---|
| Perioperative period | |||
| Death | 2/72 (2.78%) | 5/46 (10.87%) | 0.0696 |
| Paraplegia | 0/72 (0.00%) | 2/46 (4.35%) | 0.0743 |
| Renal failure | 1/72 (1.39%) | 17/46 (36.96%) | <0.0001 |
| Unilateral renal infarction | 5/72 (6.94%) | 4/46 (8.70%) | 0.7267 |
| Intestinal paralysis/necrosis | 1/72 (1.39%) | 4/46 (8.70%) | 0.0546 |
| Respiratory failure | 0/72 (0.00%) | 5/46 (10.87%) | 0.0043 |
| Deep venous thrombosis | 0/72 (0.00%) | 4/46 (8.70%) | 0.0109 |
| Postoperative follow-up | |||
| Death | 5/70 (7.14%) | 4/41 (9.76%) | 0.6264 |
| Unplanned reoperation | 3/70 (4.29%) | 6/41 (14.63%) | 0.0539 |
| Surgical/aneurysm-related deaths | 7/72 (9.72%) | 9/46 (19.57%) | 0.1277 |
Outcomes.
Discussion
The main aortic diseases involving the visceral arterial branches, including the renal arteries, celiac trunk and superior mesenteric artery, are TAAA, AD and AAA. TAAAs remains a challenging clinicopathology involving the visceral arteries, although it accounts for only 7%–15% of all aortic and peripheral aneurysms (). TAAAs are mostly caused by aortic degeneration and have poor prognoses, with a 42%–70% probability of untreated rupture after diagnosis and an average survival time of 3 years (). AAD refers to an aortic dissection involving the aorta below the diaphragm and is divided into two main types (–). The first type is an isolated abdominal aortic dissection (IAAD), which involves rupture of the abdominal aorta only and accounts for approximately 1%–4% of all aortic dissection cases. The other type is secondary thoracic aortic coarctation, which results from the continuation of the lesion into the abdominal aorta following an aortic tear, which is more common. A common characteristic of these lesions is their involvement with the visceral branch arteries, so it may be necessary to reconstruct these visceral artery branches during surgery. The choice of treatment depends primarily on the pathology of the aneurysm, the extent of the lesion and the patient's condition.
Thoracoabdominal aortic replacement is still one of the most difficult surgical approaches due to the associated vital structures, such as the visceral/renal branches and the segmental arteries involved in the lesion. First reported by Etheredge in 1955, open surgery has been the preferred treatment for this type of aortic disease, especially TAAA (). Open surgery is not only traumatic, as it requires an incision of the chest, abdomen, and diaphragm, it also requires cardiopulmonary bypass, thereby leading to coagulation disorders (, ). Recent reports from high-volume aortic centers have shown that the mortality rate after open repair in young patients (younger than age 50 years) ranges from 3% to 6%, and the mortality rate in older patients remains 8%–17% (, ). Since Crawford proposed the inclusion technique for the treatment of TAAA in 1978, the outcome of the surgery has improved significantly due to the use of adjunctive procedures, including selective visceral perfusion, distal aortic perfusion and cerebrospinal fluid drainage (–). Despite advances in surgical technique, spinal cord protection and postoperative intensive care support, patients undergoing open surgery still have a 30-day mortality rate of 7%–17% (). Fifty percent of patients have a significant risk of complications, including cardiac ischemia, pulmonary events, hemorrhage, spinal cord ischemia and acute renal failure (, ). Even though these outcomes are poor, selective repair remains necessary, since the 2- and 5-year mortality rates of patients who do not undergo an operation are 76% and more than 95%, respectively ().
Another alternative approach to traditional thoracoabdominal aortic replacement is endovascular aortic repair (EVAR) with stent grafts. Using a stent graft, Parodi pioneered the minimally invasive treatment of abdominal aortic aneurysms in 1991 (). In 1994, Dake performed a thoracic endovascular aneurysm repair to successfully treat a descending aortic aneurysm (). EVAR can be performed percutaneously using a transfemoral method, avoiding thoracoabdominal incisions, diaphragm division, left heart or cardiopulmonary bypass and cross-clamping of the aorta. There is uninterrupted aortic flow and perfusion of the internal organs and lower limb vessels during the procedure. EVAR therefore radically reduces the physiological demands, the risk of end organ ischemia, blood loss, fluid requirements and the need for transfusion products. EVAR is a suitable treatment for older, weaker and higher risk patients who have been previously regarded as unsuitable candidates for open surgery. In the last decade, the number of EVARs has doubled, and its feasibility has already been demonstrated (, ). With the progress of EVAR, more abdominal aortic diseases involving the visceral arteries can be treated with these methods, including visceral parallel graft (chimney/snorkel) techniques, multibranched stent graft and fenestrated techniques (). When the coeliac trunk, superior mesenteric and renal arteries are from a nonaneursymal implantation site, a simple hole (fenestration) in the stent graft is sufficient. When these arteries arise from the aneurysm, flow must be carried across the aneurysm through branches of the stent graft. Despite these advances, there are shortcomings and other anatomical limitations. Small vessels, such as the intercostal arteries, cannot be reconstructed by endovascular methods in most cases, raising concerns that extensive aortic coverage may increase the risk of spinal cord injury (). Some papers have shown that compared to open surgical repair, endovascular aortic repair and subrenal endovascular repair is associated with better quality of life indicators at 1 year postoperatively (). Three-dimensional, laser and customized branch/bifurcation stent grafts have been introduced for the treatment of TAA. These new technologies are constantly advancing to facilitate better individualized treatment (–). There is no doubt that a total endovascular approach would benefit patients in poor conditions (, ).
Hybrid surgery, a combination of open and endovascular techniques, for the treatment of aortic disease has been suggested to reduce surgical injury and improve outcomes, especially in high-risk patients, and was first reported in 1999 (). The hybrid surgery provides sufficient anchorage for EVAR through open visceral artery reconstruction and “transfer” from the diseased aorta to the healthier aorta. Thus, hybrid surgery can be widely used in patients with paravisceral aneurysms (). Compared to traditional thoracoabdominal aortic replacement, hybrid repair avoids the need for thoracotomy, extracorporeal perfusion, and supraceliac aortic clamping, and therefore, hemodynamics is more stable intraoperatively and there is less risk of causing an ischemia‒reperfusion injury to the visceral organs (). It significantly decreases postoperative pain and the incidence of pulmonary complications in patients with underlying pulmonary diseases (). The disadvantage is that it still requires laparotomy. For abdominal obesity, exposure of the superior mesenteric artery and coeliac trunk is difficult, intraoperative damage to the pancreatic duct may lead to the formation of postoperative pancreatic cysts, and damage to the portal vein may lead to postoperative bleeding. In addition, postoperative intestinal obstruction or swelling may affect the patient's respiration (). Although hybrid repair was developed as a less invasive approach than traditional open surgery, the 30-day mortality rate after hybrid techniques in many reports is disappointingly high (e.g., operative mortality, 3.6%–12.5% and renal failure, 20%), which has been attributed to the use of the technique in patients who are unsuitable or considered to be high-risk open surgery patients (, ). Although hybrid surgery has been debated, its efficacy and safety in treating aortic disease has been recognized in the 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (Class IIa/C evidence) ().
In fact, several patients selected for hybrid surgery are not suitable for open repair because they have severe medical comorbidities. Another benefit of hybrid surgery is that it can be used in emergencies or for patients with acute cases of ruptured TAAAs or TAADs with poor perfusion who have severe respiratory or cardiac disease and are unlikely to survive open repair. There are no other repair options, with current endovascular techniques, for these patients because there are no available fenestrated stent grafts for narrow true lumens, branch stents that can be easily introduced into small spaces that limit maneuverability, branch arteries fed by the false lumen, and no distal healthy anchor zone. In our surgical practice, we consider elective hybrid surgery for patients who are unable to undergo major thoracoabdominal procedures, who have connective tissue disorders and whose anatomy does not allow EVAR.
Since 2019, we have performed debranching abdominal aortic hybrid surgery on 72 patients with aortic disease involving the visceral arteries, using the Viabahn for some of them. Preoperative CTA showed that all patients had lesions involving the abdominal aorta and visceral arteries. A transabdominal abdominal approach is usually performed to expose the entire abdominal aorta and target vessels. Retrograde extra-anatomic bypass of the abdominal axis, superior mesenteric artery, and bilateral renal arteries is performed by using the iliac artery as the inflow port. In patients with aortic coarctation resulting in iliac artery disease, subrenal aortic replacement is considered. However, one clear disadvantage of anastomosis of the branches is the renal ischemia time. Standard suture anastomosis in renal arteries inevitably requires a long renal ischemic time of 25 min (). Although hybrid surgery reduced the renal ischemic time to approximately 10 min, we found that the Viabahn reduced the renal ischemic time further by avoiding the need for a suture anastomosis and extensively exposing the renal artery (). Our limited experience has shown that the Viabahn technique is workable and effective in all planned procedures, regardless of the anatomical location or quality of the visceral vessels.
The aims of our study were to to introduce a relatively less invasive surgical approach for patients in high-risk and high-age populations and to compare the differences between thoracoabdominal aortic replacement and hybrid surgery for aortic disease involving the visceral arteries in terms of mortality and complication rates (e.g., renal failure, unilateral renal infarction, intestinal paralysis/necrosis, respiratory failure, and deep venous thrombosis). There are very few studies that have compared these two methods. We present a hybrid surgery using the Viabahn for the treatment of the renal artery, which prevents stenosis of the renal artery anastomosis, avoids the need for ice chips, and shortens the length of renal artery decortication and the time of renal ischemia. As seen in our statistics, the rate of transient renal failure after hybridization was significantly lower. However, the rates of unilateral renal infarction and mortality at the follow-up visit following hybrid surgery were not significantly different from those following conventionally open surgery. During the follow-up period, three patients who underwent hybrid surgery underwent unplanned reoperation for reasons that included bridge vessel occlusion and endoleak.
It is evident that debranching abdominal aortic hybrid surgery also has limitations. First, endoleaks are an important cause of failure, and lesion development can lead to retrograde tearing of the dissection or enlargement and rupture of the aneurysm. Second, the current option for the inflow site is mainly a retrograde path, which has the risk of distant anastomotic stenosis and even branch occlusion. Viabahn's dislodgement or movement is one of the few undesirable occurrences. This can lead to an associated renal infarction with renal artery occlusion. Finally, the most important concern is that open repair is a major, technically challenging approach, particularly when complete visceral and/or renal revascularization is needed. The abdominal complications associated with an incision of the abdomen is a concern for doctors.
We also consider how to avoid these problems in our management. First, we ligate or suture the proximal end of the visceral artery during the debranching operations and then select an adequate anchorage as well as a stent graft of an appropriate size. Next, we performed a separation anterior to the left renal fascia and anastomosis of the synthetic grafts in the left iliac artery. The advantage of this is that the exposure is adequate, the anastomosis is more favorable, and the synthetic grafts are less prone to distortion. Finally, and most importantly, the Viabahn is used to perform a “no stitching anastomosis” of the aortic branches of the renal viscera in the debranching procedure. This tool avoids exposure and the need for anastomosis, which are technically demanding, reduces the interruption of blood and simplifies the procedure. However, we securely fix the Viabahn by suturing or tying knots from the outside where the Viabahn and the graft are in contact.
Hybrid surgery has the advantages of both EVAR and thoracoabdominal aortic replacement. The role of endovascular techniques in the treatment of aortic disease continues to develop. Hybrid surgery does not replace conventional open surgery but offers an option for high-risk patients who may be denied treatment. The long-term efficacy of hybrid surgery has yet to be elucidated, and patients still require routine surveillance to monitor for endoleak development. However, limited studies have shown results and outcomes that are favorable to hybrid surgery.
The biggest limitation of our study is the sample size of the hybrid group, as patients underwent surgery in different cities, leading to missing data and preventing a complete comparison of the metrics during surgery. The quality of the study was also limited by the asynchronous nature of the two groups, the economic status of the patients and the retrospective nature. Studies with a large series of patients with detailed medical histories and a longer follow-up are necessary to provide meaningful statistics for debranching abdominal aortic hybrid surgery for aortic diseases involving the visceral arteries and visceral artery reconstructions with the Viabahn.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving human participants were reviewed and approved by Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Institutional Review Board document number TJ-JRB20230516). Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
Author contributions
Conception and design: XW, XF, and CC. Analysis and interpretation: XM, SL, CC, and XF. Data collection: BQ, YF, and XF. Writing the article: XM, QZ, CC, and YF. Critical revision of the article: CC and XF. Final approval of the article: CC and XF. Statistical analysis: YF, WA, MAT and XM. Overall responsibility: XM, YF, CC, and XF. All authors contributed to the article and approved the submitted version.
Funding
This study was supported by the Hubei Provincial Science and Technology Major Project (2022ACA002).
Acknowledgments
We acknowledge assistance from Min Hu and Jun Chen (Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) for contribution to this article. We thank the study participants.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
KabbaniLSCriadoEJrUGPatelHJEliasonJLRectenwaldJet alHybrid repair of aortic aneurysms involving the visceral and renal vessels. Ann Vasc Surg. (2010) 24(2):219–24. 10.1016/j.avsg.2009.08.007
2.
CochennecFMarzelleJ. Les syndromes aortiques aigus [acute aortic syndromes]. Presse Med. (2018) 47(2):140–52. 10.1016/j.lpm.2018.02.001
3.
SmithTAGatensSAndresMModrallJGClagettGPArkoFR. Hybrid repair of thoracoabdominal aortic aneurysms involving the visceral vessels: comparative analysis between number of vessels reconstructed, conduit, and gender. Ann Vasc Surg. (2011) 25(1):64–70. 10.1016/j.avsg.2010.06.004
4.
YamaguchiHMurataSOnozawaSSugiharaFHayashiHKumitaSI. Strategy for the treatment of spontaneous isolated visceral artery dissection. Eur J Radiol Open. (2018) 6:9–15. 10.1016/j.ejro.2018.11.003
5.
RosenblumJMChenEP. Thoracoabdominal aortic aneurysm repair: open, endovascular, or hybrid?Gen Thorac Cardiovasc Surg. (2019) 67(1):175–9. 10.1007/s11748-017-0820-y
6.
EtheredgeSNYeeJSmithJVSchonbergerSGoldmanMJ. Successful resection of a large aneurysm of the upper abdominal aorta and replacement with homograft. Surgery. (1955) 38(6):1071–81. 10.1016/0371-1951(55)80039-2
7.
LiYLiZFengJFengRZhouJJingZ. A novel solution for distal dilation of chronic dissection after repair involving visceral branches: the roadblock strategy. Front Cardiovasc Med. (2022) 9:821260. 10.3389/fcvm.2022.821260
8.
KhouryMKAcherCWynnMMAcherCW. Long-term survival after descending thoracic and thoracoabdominal aortic aneurysm repair. J Vasc Surg. (2021) 74(3):843–50. 10.1016/j.jvs.2021.02.048
9.
PolancoARD'AngeloAMSheaNJAllenPTakayamaHPatelVI. Increased hospital volume is associated with reduced mortality after thoracoabdominal aortic aneurysm repair. J Vasc Surg. (2021) 73(2):451–8. 10.1016/j.jvs.2020.05.027
10.
PatelRSweetingMJPowellJTGreenhalghRM, EVAR trial investigators. Endovascular versus open repair of abdominal aortic aneurysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial. Lancet. (2016) 388(10058):2366–74. 10.1016/S0140-6736(16)31135-7
11.
KheirelseidEAGardinerRHaiderSNMartinZColganMPO'NeillSMet alEndovascular repair of thoracoabdominal aortic aneurysm (TAAA): early experience. Ir J Med Sci. (2014) 183(2):153–60. 10.1007/s11845-013-0974-2
12.
EagletonMJFollansbeeMWolskiKMastracciTKuramochiY. Fenestrated and branched endovascular aneurysm repair outcomes for type II and III thoracoabdominal aortic aneurysms. J Vasc Surg. (2016) 63(4):930–42. 10.1016/j.jvs.2015.10.095
13.
PecoraroFPfammatterTMayerDFrauenfelderTPapadimitriouDHechelhammerLet alMultiple periscope and chimney grafts to treat ruptured thoracoabdominal and pararenal aortic aneurysms. J Endovasc Ther. (2011) 18(5):642–9. 10.1583/11-3556.1
14.
ChuterTAGordonRLReillyLMGoodmanJDMessinaLM. An endovascular system for thoracoabdominal aortic aneurysm repair. J Endovasc Ther. (2001) 8(1):25–33. 10.1177/152660280100800104
15.
ZymvragoudakisVSahaPGkoutziosPZayedHAbisiS. Use of the off-the-shelf pre-cannulated E-nside endograft to overcome anatomical challenges in urgent complex endovascular aortic repair. Ann Vasc Surg. (2022) 79:441.e1–e7. 10.1016/j.avsg.2021.07.045
16.
ArakawaMSumikuraHOkamuraHMiyagawaAHommaAYamaguchiA. A three-dimensional biomodel of type A aortic dissection for endovascular interventions. J Artif Organs. (2022) 25(2):125–31. 10.1007/s10047-021-01294-0
17.
QinJWuXLiWYeKYinMLiuGet alLaser fenestration of aortic arch stent grafts for endovascular treatment of retrograde type A dissection. Int J Cardiol. (2021) 328:69–74. 10.1016/j.ijcard.2020.12.011
18.
BenrashidEWangHAndersenNDKeenanJEMcCannRLHughesGC. Complementary roles of open and hybrid approaches to thoracoabdominal aortic aneurysm repair. J Vasc Surg. (2016) 64(5):1228–38. 10.1016/j.jvs.2016.04.022
19.
HuangBYuanDZhaoJMaY. Hybrid treatment of a thoracoabdominal aortic aneurysm in China: report of the first successful case. Surg Today. (2012) 42(12):1219–24. 10.1007/s00595-012-0164-2
20.
SimmonsMNSchreiberMJGillIS. Surgical renal ischemia: a contemporary overview. J Urol. (2008) 180(1):19–30. 10.1016/j.juro.2008.03.022
21.
PapadimasETanYKQiQNgJJKofidisTTeohKet alLeft heart bypass versus circulatory arrest for open repair of thoracoabdominal aortic pathologies. ANZ J Surg. (2020) 90(12):2434–40. 10.1111/ans.16287
22.
BickerstaffLKPairoleroPCHollierLHMeltonLJVan PeenenHJCherryKJet alThoracic aortic aneurysms: a population-based study. Surgery. (1982) 92(6):1103–8. 10.1055/s-0029-1245288
23.
LeMaireSAPriceMDGreenSYZardaSCoselliJS. Results of open thoracoabdominal aotic aneurysm repair. Ann Cardiothorac Surg. (2012) 1:286–92. 10.3978/j.issn.2225-319X.2012.08.16
24.
TrimarchiSTsaiTEagleKAIsselbacherEMFroehlichJCooperJVet alAcute abdominal aortic dissection: insight from the international registry of acute aortic dissection (IRAD). J Vasc Surg. (2007) 46(5):913–9. 10.1016/j.jvs.2007.07.030
25.
ErbelRAboyansVBoileauCBossoneEBartolomeoRDEggebrechtHet al2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC). Eur Heart J. (2014) 35(41):2873–926. 10.1093/eurheartj/ehu281
26.
ZlatanovicPDragasMCvetkovicSDimicAMitrovicAVujcicAet alOpen surgical treatment of acute spontaneous isolated abdominal aortic dissection. Ann Vasc Surg. (2021) 74:525.e13–e21. 10.1016/j.avsg.2021.02.035
27.
CoselliJSBozinovskiJLeMaireSA. Open surgical repair of 2286 thoracoabdominal aortic aneurysms. Ann Thorac Surg. (2007) 83:S862–4; discussion: S890–2. 10.1016/j.athoracsur.2006.10.088
28.
ConradMFCrawfordRSDavisonJKCambriaRP. Thoracoabdominal aneurysm repair: a 20-year perspective. Ann Thorac Surg. (2007) 83:S856–61; discussion: S890–2. 10.1016/j.athoracsur.2006.10.096
29.
CoselliJSAmarasekaraHSGreenSYPriceMDPreventzaOde la CruzKIet alOpen repair of thoracoabdominal aortic aneurysm in patients 50 years old and younger. Ann Thorac Surg. (2017) 103:1849–57. 10.1016/j.athoracsur.2016.09.058
30.
TanakaASandhuHKAffiROMillerCC3rdRayAHassanMet alOutcomes of open repairs of chronic distal aortic dissection anatomically amenable to endovascular repairs. J Thorac Cardiovasc Surg. (2021) 161(1):36–43.e6. 10.1016/j.jtcvs.2019.09.083
31.
CrawfordESSnyderDMChoGCRoehmJO. Progress in treatment of thoracoabdominal and abdominal aortic aneurysms involving celiac, superior mesenteric, and renal arteries. Ann Surg. (1978) 188:404–10. 10.1097/00000658-197809000-00016
32.
CoselliJSConklinLDLeMaireSA. Thoracoabdominal aortic aneurysm repair: review and update of current strategies. Ann Thorac Surg. (2002) 74:S1881–4. 10.1016/S0003-4975(02)04139-5
33.
CoselliJS. The use ofleft heart bypass in the repair of thoracoabdominal aortic aneurysms: current techniques and results. Semin Thorac Cardiovasc Surg. (2003) 15:326–32. 10.1053/S1043-0679(03)00090-X
34.
Quinones-BaldrichWJ. Descending thoracic and thoracoabdominal aortic aneurysm repair: 15-year results using a uniform approach. AnnVasc Surg. (2004) 18:335–42. 10.1007/s10016-004-0033-6
35.
FrederickJRWooYJ. Thoracoabdominal aortic aneurysm. Ann Cardiothorac Surg. (2012) 1:277–85. 10.1007/978-3-642-00418-6_2292
36.
CowanJAJrDimickJBHenkePKHuberTSStanleyJCUpchurchGRJr. Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes. J Vasc Surg. (2003) 37(6):1169–74. 10.1016/S0741-5214(03)00085-5
37.
CrawfordESDe NataleRW. Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease. J Vas Surg. (1986) 3:578–82. 10.1016/0741-5214(86)90281-8
38.
ParodiJCPalmazJCBaroneHD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg. (1991) 5(6):491–9. 10.1007/BF02015271
39.
DakeMDMillerDCSembaCPMitchellRSWalkerPJLiddellRP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med. (1994) 331(26):1729–34. 10.1056/NEJM199412293312601
40.
GreenbergRKWestKPfaffKFosterJSkenderDHaulonSet alBeyond the aortic bifurcation: branched endovascular grafts for thoracoabdominal and aortoiliac aneurysms. J Vasc Surg. (2006) 43:879–86. 10.1016/j.jvs.2005.11.063
41.
HanYZhangSZhangJJiCEcksteinHH. Outcomes of endovascular abdominal aortic aneurysm repair in octogenarians: meta-analysis and systematic review. Eur J Vasc Endovasc Surg. (2017) 54(4):454–63. 10.1016/j.ejvs.2017.06.027
42.
TenorioERDias-NetoMFLimaGBBEstreraALOderichGS. Endovascular repair for thoracoabdominal aortic aneurysms: current status and future challenges. Ann Cardiothorac Surg. (2021) 10(6):744–67. 10.21037/acs-2021-taes-24
43.
MaurelBDelclauxNSobocinskiJHertaultAMartin-GonzalezTMoussaMet alThe impact of early pelvic and lower limb reperfusion and attentive peri-operative management on the incidence of spinal cord ischemia during thoracoabdominal aortic aneurysm endovascular repair. Eur J Vasc Endovasc Surg. (2015) 49(3):248–54. 10.1016/j.ejvs.2014.11.017
44.
KärkkäinenJMSandriGATenorioERMacedoTAHoferJGloviczkiPet alProspective assessment of health-related quality of life after endovascular repair of pararenal and thoracoabdominal aortic aneurysms using fenestrated-branched endografts. J Vasc Surg. (2019) 69(5):1356–1366.e6. 10.1016/j.jvs.2018.07.060
45.
OderichGSRibeiroMHoferJWighamJChaSChiniJ. Prospective, nonrandomized study to evaluate endovascular repair of pararenal and thoracoabdominal aortic aneurysms using fenestrated-branched endografts based on supraceliac sealing zones. J Vasc Surg. (2017) 65(5):1249–1259.e10. 10.1016/j.jvs.2016.09.038
46.
GallittoEFaggioliGMelissanoGFargionAIserniaGLentiM. Preoperative and postoperative predictors of clinical outcome fenestrated and branched endovascular repair for complex abdominal and thoracoabdominal aortic aneurysms in an Italian multicenter registry. J Vasc Surg. (2021) 74(6):1795–1806.e6. 10.1016/j.jvs.2021.04.072
47.
Quiñones-BaldrichWJPanettaTFVesceraCLKashyapVS. Repair of type IV thoracoabdominal aneurysm with a combined endovascular and surgical approach. J Vasc Surg. (1999) 30(3):555–60. 10.1016/S0741-5214(99)70084-4
48.
BellKELopezAC. Hybrid repair of thoracoabdominal aneurysms: a combined endovascular and open approach. J Vasc Nurs. (2008) 26(4):101–8. 10.1016/j.jvn.2008.09.001
49.
TanakaAOderichGSEstreraAL. Total abdominal debranching hybrid thoracoabdominal aortic aneurysm repair versus chimneys and snorkels. JTCVS Tech. (2021) 10:28–33. 10.1016/j.xjtc.2021.08.002
50.
YangGZhangMMuzepperMDuXWangWLiuCet alComparison of physician-modified fenestrated/branched stent-grafts and hybrid visceral debranching plus stent-graft placement for complex thoracoabdominal aortic aneurysm repair. J Endovasc Ther. (2020) 27(5):749–56. 10.1177/1526602820934466
51.
LjungmanCWanhainenAKragstermanBNymanRErickssonLGEriksson. Propositions for refinement of the hybrid surgical technique for treatment of thoraco-abdominal aortic aneurysm. Scand J Surg. (2008) 97(2):174–7. 10.1177/145749690809700221
52.
ArnaoutakisDJScaliSTBeckAWKubilisPHuberTSMartinAJ. Comparative outcomes of open, hybrid, and fenestrated branched endovascular repair of extent II and III thoracoabdominal aortic aneurysms. J Vasc Surg. (2020) 71(5):1503–14. 10.1016/j.jvs.2019.08.236
53.
RiambauVBöcklerDBrunkwallJCaoPChiesaRCoppiG. Editor’s choice—management of descending thoracic aorta diseases: clinical practice guidelines of the European society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg. (2017) 53(1):4–52. 10.1016/j.ejvs.2016.06.005
54.
ChiesaRKahlbergAMasciaDTshombaYCiviliniEMelissanoG. Use of a novel hybrid vascular graft for sutureless revascularization of the renal arteries during open thoracoabdominal aortic aneurysm repair. J Vasc Surg. (2014) 60:622e30. 10.1016/j.jvs.2014.03.256
55.
HughesGCBarfieldMEShahAAWilliamsJBKuchibhatlaMHannaJM. Staged total abdominal debranching and thoracic endovascular aortic repair for thoracoabdominal aneurysm. J Vasc Surg. (2012) 56(3):621–9. 10.1016/j.jvs.2011.11.149
Summary
Keywords
aortic disease, visceral artery, thoracoabdominal aortic replacement, endovascular aortic repair, hybrid surgery
Citation
Ma X, Feng Y, Tardzenyuy MA, Qin B, Zhu Q, Akilu W, Li S, Wei X, Feng X and Cheng C (2023) Debranching abdominal aortic hybrid surgery for aortic diseases involving the visceral arteries. Front. Cardiovasc. Med. 10:1219788. doi: 10.3389/fcvm.2023.1219788
Received
09 May 2023
Accepted
15 June 2023
Published
13 July 2023
Volume
10 - 2023
Edited by
Xiangjiu Ding, Shandong University, China
Reviewed by
Jiang Xiong, People’s Liberation Army General Hospital, China Weixun Duan, Fourth Military Medical University, China
Updates
Copyright
© 2023 Ma, Feng, Tardzenyuy, Qin, Zhu, Akilu, Li, Wei, Feng and Cheng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiang Feng 13621951368@163.com Cai Cheng cai.cheng@hotmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.